EUVIMEDEUVIMED entdecken
Crossref

Non-syndromic congenital sideroblastic anaemia; phenotype, and genotype of 15 Indian patients

Rashmi Dongerdiye, Prabhakar S Kedar, Arati Saptarshi, Abhilasha Sampagar, Chandrakala Shanmukhaiah, Sangeeta Mudaliar, Purva Kanvinde, Mukesh Desai, Manisha Madkaikar

Annals of Hematology · 2024

DOI: 10.1007/s00277-024-05969-5 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Annals of Hematology, 2024. Verfasst von Rashmi Dongerdiye und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Haematogenetics, ICMR-National Institute of Immunohematology, Indian Council of Medical Research, 13th Floor, NMS Building, King Edward…. Hauptthemen laut MEDLINE: Anemia, Sideroblastic, 5-Aminolevulinate Synthetase. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 21 Literaturangaben. Gefördert von: Indian Council of Medical Research.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Sideroblastic anaemias are a diverse group of congenital and acquired bone marrow failure disorders marked by the presence of ring sideroblasts, ineffective erythropoiesis, and systemic iron overload. Congenital Sideroblastic anaemia (CSA) is mainly caused by gene mutations associated with heme synthesis, iron-sulfur [Fe-S] cluster, and mitochondrial protein synthesis pathways. The most prevalent form of CSA is caused by mutations in the erythroid-specific -amino levulinate synthase (ALAS2) gene, which encodes the first enzyme in the heme synthesis pathway in red blood cells. The second most prevalent form of CSA is caused by a mutation in the Solute carrier family 25 member 38 (SLC25A38) gene, which codes for an erythroid-specific protein of the inner mitochondrial membrane. Additionally, 15-20 genes are altogether associated with CSA. In this study, we aim to identify the CSA patients, understand their genetics and establish genotype-phenotype correlation. We have identified fifteen cases of CSA using our targeted NGS (t-NGS) panel. The major clinical findings in our cohort were microcytic anaemia, ring sideroblasts, and dyserythropoiesis in the bone marrow. Currently, two patients are responsive to pyridoxine, while the rest are on blood transfusion support. We have identified ten variants in three different genes of CSA (ALAS2, SLC25A38 & HSPA9). Five patients harbour four hemizygous variants- p.Ala282Ser, p.Arg170Cys, p.Arg204Gln and exon 2 duplication in the ALAS2 gene. In seven patients, we have identified three homozygous mutations - p.Pro190Arg, p.Arg187Gln and p.Arg134Cys in the SLC25A38 gene. These mutations have been predominantly identified in the European population. Three patients revealed three heterozygous variants p. Thr463Ile, D326Tyr, and Arg284Trp in the HSPA9 gene. PyMoL was used to evaluate the functional effects of these variations and understand their effect on the structure of the protein. We believe that by combining a bone marrow examination with genetic sequencing, CSA patients can acquire a definitive diagnosis.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Anemia, Sideroblastic5-Aminolevulinate SynthetaseHumansMaleFemaleChildIndiaChild, PreschoolInfantMitochondrial Membrane Transport ProteinsAdolescentGenetic Association StudiesGenotypePhenotypeMutationAdultGenetic Diseases, X-Linked

Stichwörter der Autor:innen

ALAS2 geneBone marrow failureCongenital sideroblastic anaemiaHSPA9 geneIneffective erythropoiesisRing sideroblastSLC25A38 gene

Substanzen

5-Aminolevulinate SynthetaseALAS2 protein, humanSlc25a38 protein, humanMitochondrial Membrane Transport Proteins

Autor:innen und Institutionen

  • Department of Haematogenetics, ICMR-National Institute of Immunohematology, Indian Council of Medical Research, 13th Floor, NMS Building, King Edward Memorial (KEM.) Hospital Campus, Parel, Mumbai, 400012, India.
  • Department of Haematogenetics, ICMR-National Institute of Immunohematology, Indian Council of Medical Research, 13th Floor, NMS Building, King Edward Memorial (KEM.) Hospital Campus, Parel, Mumbai, 400012, India. kedarp…
  • Pediatric Hematologist Oncologist, KLE'S Dr Prabhakar Kore Hospital, Belagavi, Karnataka, India.
  • Department of Haematology, KEM Hospital, 10th Floor, NMS Building, Parel, Mumbai, 400012, India.
  • Department of Haematology-Oncology, B J Wadia Hospital, Parel, Mumbai, 400012, India.

Förderung

  • Indian Council of Medical Research

Zitieren

APA

Dongerdiye, R., Kedar, P. S., Saptarshi, A., Sampagar, A., Shanmukhaiah, C., Mudaliar, S., Kanvinde, P., Desai, M., & Madkaikar, M. (2024). Non-syndromic congenital sideroblastic anaemia; phenotype, and genotype of 15 Indian patients. Annals of Hematology. https://doi.org/10.1007/s00277-024-05969-5

Vancouver

Dongerdiye R, Kedar PS, Saptarshi A, Sampagar A, Shanmukhaiah C, Mudaliar S, et al. Non-syndromic congenital sideroblastic anaemia; phenotype, and genotype of 15 Indian patients. Annals of Hematology. 2024. doi:10.1007/s00277-024-05969-5

BibTeX
@article{Dongerdiye2024,
  author = {Dongerdiye, Rashmi and Kedar, Prabhakar S and Saptarshi, Arati and Sampagar, Abhilasha and Shanmukhaiah, Chandrakala and Mudaliar, Sangeeta and Kanvinde, Purva and Desai, Mukesh and Madkaikar, Manisha},
  title = {Non-syndromic congenital sideroblastic anaemia; phenotype, and genotype of 15 Indian patients},
  journal = {Annals of Hematology},
  year = {2024},
  doi = {10.1007/s00277-024-05969-5}
}
Kostenlos starten →